Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion type Assertion NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_head.
- NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion description "[Cross-talk between AKT and estrogen receptor beta-mediated transcription pathways may represent an important aspect that may influence breast cancer response to endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_provenance.
- NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion evidence source_evidence_literature NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_provenance.
- NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion SIO_000772 16951146 NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_provenance.
- NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion wasDerivedFrom lhgdn-20090331 NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_provenance.
- NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_assertion wasGeneratedBy ECO_0000203 NP171033.RAtEQcDNQKtCi42E_f9KtsA_9oAGehOR3kVO7WC9uzr6I130_provenance.